Effect of absolute ethanol embolization on the function of liver and kidney in patients with vascular malformations: A prospective evaluation

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900022040

Enrollment

Unknown

Registered

2019-03-21

Start date

2019-03-25

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular Malformations

Interventions

Treatment group:Absolute ethanol embolization

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with vascular malformations and meet the indications of absolute ethanol embolization; 2. Patients agrees to participate in the clinical trial

Exclusion criteria

Exclusion criteria: With a history of liver or kidney disease, or other systematic diseases.

Design outcomes

Primary

Measure	Time frame
Indicators of liver function;Indicators of kidney function;routine blood and urine tests;	—

Secondary

Measure	Time frame
uncomfort feelings;	—

Countries

China

Contacts

Public ContactXin-dong Fan

fanxindong@aliyun.com+86 021-2965666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026